Clinical Trials Directory

Trials / Conditions / EBV Infection

EBV Infection

19 registered clinical trials studyying EBV Infection — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingZuberitamab for EBV Infection Post-Allo-HSCT
NCT07261215
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
RecruitingIs Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A S
NCT07294547
National Taiwan University HospitalN/A
Enrolling By InvitationInvestigating Epstein-Barr Virus Associated Conjunctivitis
NCT06689397
Moorfields Eye Hospital NHS Foundation Trust—
UnknownMultivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
NCT06075927
Peking University People's HospitalPhase 1 / Phase 2
RecruitingClinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection
NCT06135922
Chinese PLA General HospitalPhase 1
UnknownA Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carci
NCT05682703
Nanfang Hospital, Southern Medical University—
CompletedRelationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis
NCT05604378
Saint Vincent's Hospital, Korea—
UnknownPD-1 Antibody for Reactive EBV After BMT
NCT04690036
Beijing Friendship HospitalEARLY_Phase 1
UnknownProgrammed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
NCT05039580
The First Affiliated Hospital of Soochow UniversityPhase 4
UnknownStudy on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases
NCT04782674
Beijing Friendship Hospital—
RecruitingStudy to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infecti
NCT04308278
Labo'LifePhase 4
CompletedEVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients
NCT04189835
University of Aarhus—
UnknownPD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
NCT04084626
Beijing Friendship HospitalPhase 3
RecruitingMultivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607
Tobias FeuchtingerPhase 3
RecruitingSurveillance and Tracking the Outcomes of Chronic Latent EBV Infection
NCT03491605
Huazhong University of Science and Technology—
Active Not RecruitingAntiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transpl
NCT03475212
Pediatric Transplantation & Cellular Therapy ConsortiumPhase 1 / Phase 2
UnknownAntigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections
NCT03159364
Shenzhen Geno-Immune Medical InstitutePhase 1 / Phase 2
CompletedMost Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)
NCT00711035
Baylor College of MedicinePhase 1 / Phase 2
No Longer AvailableAllogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CH
NCT01945619
Baylor College of Medicine—